RXDX

Prometheus Biosciences, Inc.

No insider bought or sold Prometheus Biosciences, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow RXDX

RXDX over the last year

Prices for RXDX aren't in yet.

RXDX after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

16 insider filings since 2016, newest first

RXDXSell

Keith W Marshall · CFO

$1.1M−50.0%Apr 7

RXDXSell

Mark C. Mckenna · Chair, President and CEO

$2.9M−31.0%Mar 17

RXDXSell

Keith W Marshall · CFO

$1.2M−50.0%Mar 8

RXDXSell

Sinai Intellectual Property Co Cedars · 10% owner

$99.1M−18.0%Mar 8

RXDXSell

Mark C. Mckenna · Chair, President and CEO

$1.4M−17.0%Mar 3

RXDXSell

Keith W Marshall · CFO

$597K−34.0%Feb 17

RXDXSell

Mark C. Mckenna · Chair, President and CEO

$7.7M−54.0%Feb 17

RXDXSell

Keith W Marshall · CFO

$595K−34.0%Jan 19

RXDXSell

Mark C. Mckenna · Chair, President and CEO

$3.0M−31.0%Jan 19

RXDXBuy

Cormorant Asset Management, LP · Former 10% Owner

$7.1M+20.0%Mar 18

RXDXBuy

Point72 Biotech Private Investments, LLC · Former 10% Owner

$15.2M+43.0%Mar 17

RXDXBuy

Joseph C Papa · Director

$285KMar 16

RXDXBuy

Perceptive Advisors LLC · 10% owner

$16.1M+34.0%Mar 16

RXDXBuy

Rtw Investments, LP · 10% owner

Mark Stenhouse · COO

Alexander W. Casdin · Director

$1.4M+40.0%May 4

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.